Woodline Partners’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.47M | Buy |
574,853
+418
| +0.1% | +$3.98K | 0.03% | 540 |
|
|
2025
Q1 | $6.01M | Buy |
574,435
+478
| +0.1% | +$5K | 0.04% | 456 |
|
|
2024
Q4 | $13.5M | Sell |
573,957
-403,483
| -41% | -$9.51M | 0.09% | 286 |
|
|
2024
Q3 | $35.1M | Sell |
977,440
-256,468
| -21% | -$9.21M | 0.3% | 108 |
|
|
2024
Q2 | $43.5M | Buy |
1,233,908
+535,981
| +77% | +$18.9M | 0.42% | 65 |
|
|
2024
Q1 | $19.8M | Buy |
697,927
+262,401
| +60% | +$7.45M | 0.18% | 172 |
|
|
2023
Q4 | $5.79M | Buy |
435,526
+99,642
| +30% | +$1.33M | 0.06% | 298 |
|
|
2023
Q3 | $3.01M | Sell |
335,884
-46,692
| -12% | -$418K | 0.04% | 359 |
|
|
2023
Q2 | $4.3M | Buy |
+382,576
| New | +$4.3M | 0.05% | 311 |
|
|
2022
Q3 | – | Sell |
-666,997
| Closed | -$4.58M | – | 771 |
|
|
2022
Q2 | $4.58M | Sell |
666,997
-146,142
| -18% | -$1M | 0.07% | 270 |
|
|
2022
Q1 | $7.84M | Buy |
813,139
+298,538
| +58% | +$2.88M | 0.13% | 196 |
|
|
2021
Q4 | $6.12M | Buy |
514,601
+298,400
| +138% | +$3.55M | 0.09% | 259 |
|
|
2021
Q3 | $3.51M | Sell |
216,201
-6,173
| -3% | -$100K | 0.06% | 307 |
|
|
2021
Q2 | $4.68M | Sell |
222,374
-160,119
| -42% | -$3.37M | 0.09% | 231 |
|
|
2021
Q1 | $5.94M | Sell |
382,493
-108,493
| -22% | -$1.68M | 0.13% | 176 |
|
|
2020
Q4 | $10.3M | Buy |
490,986
+224,187
| +84% | +$4.71M | 0.27% | 114 |
|
|
2020
Q3 | $5.39M | Buy |
+266,799
| New | +$5.39M | 0.18% | 123 |
|